July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Lysosomal impairment in the Retinal Pigment Epithelium (RPE) - a pathway of damage in the ageing retina
Author Affiliations & Notes
  • Eloise Keeling
    Clinical & Experimental Sciences, Medicine, University of Southampton, Southampton, United Kingdom
  • David A. Johnston
    Biomedical Imaging Unit, University of Southampton, Southampton, United Kingdom
  • David S. Chatelet
    Biomedical Imaging Unit, University of Southampton, Southampton, United Kingdom
  • David Tumbarello
    Biological Sciences, Faculty of Natural & Environmental Sciences, University of Southampton, Southampton, United Kingdom
  • Andrew Lotery
    Clinical & Experimental Sciences, Medicine, University of Southampton, Southampton, United Kingdom
    Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
  • J. Arjuna Ratnayaka
    Clinical & Experimental Sciences, Medicine, University of Southampton, Southampton, United Kingdom
  • Footnotes
    Commercial Relationships   Eloise Keeling, None; David A. Johnston, None; David S. Chatelet, None; David Tumbarello, None; Andrew Lotery, None; J. Arjuna Ratnayaka, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4487. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eloise Keeling, David A. Johnston, David S. Chatelet, David Tumbarello, Andrew Lotery, J. Arjuna Ratnayaka; Lysosomal impairment in the Retinal Pigment Epithelium (RPE) - a pathway of damage in the ageing retina. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4487.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A key function of the RPE is the phagocytosis/degradation of photoreceptor outer segments (POS). In age and disease, this pathway becomes impaired and lipofuscin accumulates within RPE lysosomes. Here, we used cultured RPE cells to identify the molecular pathways through which damage to the endosomal-lysosomal system occurs.

Methods : We developed an ex-vivo model of the RPE monolayer in which cells structurally and functionally resemble native RPE1. ARPE-19 cells were fed 4mg/cm2 POS-FITC. To optimise POS binding whilst synchronising internalisation2, cultures were incubated with POS for 30min at 17oC after which cells were returned to a 37oC incubator before fixation with 4% PFA at 2, 4, 6, 12, 24 and 48hrs. In order to mimic oxidative stress, cultures were pre-treated with 200mM Hydrogen Peroxide (H2O2) for 24hrs. Parallel cultures were pre-treated with 10nM Bafilomycin (Baf) for 48Hrs, which blocks vATPase mimicking effects of the lipofuscin-derivative A2E3. DMSO was fed to sister cultures as a control. Cells on transwell inserts were stained with endosomal (Rab5, Rab7), lysosomal (Lamp1, Lamp2), and autophagy marker (LC3B) for each time point. Data from n>6 cells/time point/treatment. Images collected on a Leica SP8 confocal microscope and analysed using Volocity (PerkinElmer).

Results : Our results show that trafficking of POS-FITC cargo occurs through endosomes, lysosomes and autophagosomes in a 2-48hr timescale. Pre-treatment with Baf increased accumulation in Rab5 and Rab7 (p<0.05) compartments at late time points (6hr-24hr), indicative of impaired maturation in late endosomes. Exposure to elevated oxidative stress (H2O2) increased cargo trafficking to lamp1/2 positive compartments between 2-4hrs (p<0.01). Exposure to Baf or H2O2 also increased the formation of autophagy bodies between 2-24hrs (p<0.05).

Conclusions : Exposure to an A2E mimic impaired maturation of late endosomes, whilst oxidative stress caused rapid trafficking of cargos to late compartments; revealing divergent mechanisms through which the RPE endosomal-lysosomal pathway becomes disrupted in old age, and how these perturbations increase autophagy. Such insights may be informative when designing future treatments.
10.1016/j.tice.2017.06.003 2. 10.1016/S0014-4835(87)80105-7 3. 10.1096/fj.03-0289fje

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×